https://masakimiura.jp/obesity-vs-obesity-disease/2026-06-19T21:42:31+09:00https://masakimiura.jp/obesity-stigma-not-self-blame/2026-06-19T21:42:32+09:00https://masakimiura.jp/obesity-and-diabetes/2026-06-19T21:42:33+09:00https://masakimiura.jp/how-to-read-glp1-obesity-drug-information/2026-06-19T21:42:34+09:00https://masakimiura.jp/medical-article-supervision-checkpoints/2026-06-19T21:42:35+09:00https://masakimiura.jp/obesity-communication-words-to-avoid/2026-06-19T21:42:36+09:00https://masakimiura.jp/overview-of-obesity-disease-treatment/2026-06-19T21:42:36+09:00https://masakimiura.jp/anti-obesity-medication-communication-points/2026-06-19T21:42:37+09:00https://masakimiura.jp/severe-obesity-specialized-treatment/2026-06-19T21:42:38+09:00https://masakimiura.jp/lifestyle-diseases-are-not-only-personal-responsibility/2026-06-19T21:42:39+09:00https://masakimiura.jp/zepbound-obstructive-sleep-apnea-indication/2026-06-19T21:42:40+09:00https://masakimiura.jp/wegovy-mash-fatty-liver-disease/2026-06-19T23:12:10+09:00https://masakimiura.jp/mash-masld-nafld-difference/2026-06-19T23:29:57+09:00